Alzheimer's disease, Sully Sullenberger
Digest more
Human brain is actually 2 separate organs, scientists find
Alzheimer’s R&D is shifting toward disease modification, with amyloid, tau, RNA and immune targets driving trials, partnerships and oral therapy opportunities.Dublin, Sept. (GLOBE NEWSWIRE) -- ...
The latest approvals expand the population of people who could be tested for the memory disorder—but experts warn the tests aren't for everyone.
The atlas of gene expression in the prefrontal cortex was created using samples from almost 1,500 donors of all ages — from infants to centenarians.
Galimedix Therapeutics, Inc., a Phase 2 clinical-stage biotechnology company developing novel oral and topical ...
This phase 2b/3, double-blind trial of oral Xanamem in 247 participants with mild to moderate Alzheimer’s disease and elevated pTau181 evaluates the potential benefit of targeting excess cortisol in ...
Nearly 400 walkers gathered for this year's Walk to End Alzheimer's in La Crosse, raising close to $95,000 to support ...
Alzheimer's disease is the most common form of dementia worldwide. Although the APOE ε4 allele is the strongest genetic risk ...
This year’s World Alzheimer’s Day theme is “The Earlier You Know, The More You Can Do: A Dementia Diagnosis Matters,” observed September 21, 2026, bringing attention to the disease and the importance ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results